Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...

Using the 2 Stage Free Cash Flow to Equity, Abbott Laboratories fair value estimate is US$152 With US$129 share price, Abbott Laboratories appears to be trading close to its estimated fair value ...

Gov. Greg Abbott issued a ban on the use of Chinese-backed artificial intelligence and social media apps on Texas government-issued devices Friday afternoon. The proclamation orders the Texas ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Health care systems are making big investments in AI, and these companies are on the bleeding edge of that transition.

It seems like Tennessee head coach Brian Callahan has some high expectations for Shedeur Sanders. Sanders met with multiple members of the Titans staff last week, including Callahan and newly ...

For exclusive news and updates, subscribe to our Abbott Elementary Newsletter: Abbott Elementary has been renewed for a fifth season at ABC amid its ongoing fourth season run at the network ...

After hours: 8:00:00 p.m. EST ...

OpenAI, the company behind ChatGPT, has announced an agreement to collaborate with U.S. National Laboratories, indicating that it plans to assist in various fields, including nuclear security.